8.2 C
Glasgow
Wednesday, March 11, 2026
spot_img

More News

Study shows AI boosts breast cancer detection by more than 10 percent

Jim Cornall -
The UK's first comprehensive evaluation of the use of artificial intelligence (AI) in breast cancer screening found that it...

First reliable biomarker test for early kidney transplant rejection detection in living-donor recipients

Jim Cornall -
New analysis in Frontiers in Medicine highlights numares Health’s urinary metabolite constellation as the first biomarker test to show...

Approval for drug to treat advanced squamous cell carcinoma of the anal canal

Jim Cornall -
Incyte has announced that the European Commission (EC) has approved Zynyz (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based...

Naobios and SGS partner to manufacture RSV challenge agent

Jim Cornall -
French CDMO Naobios and SGS are partnering to manufacture a respiratory syncytial virus (RSV) challenge agent for use in...

New approach to drug development

Jim Cornall -
In a recently published review, a research team led by MedUni Vienna has highlighted a promising new approach to...

Base to Base biotech podcast 49: Gene therapy for kidney disease, and using AI to transform diagnostics

Jim Cornall -
This week, we’re chatting with Haseeb Ahmad, CEO of Purespring Therapeutics, about gene therapies in kidney disease, and with...

Antifibrotic drug shows promise for premature ovarian insufficiency

Jim Cornall -
Premature ovarian insufficiency (POI) is a clinically significant cause of infertility that affects between 1 and 3% of women...

Immune cells remember their location

Jim Cornall -
A new AI-based method reconstructs spatial information about where immune cells were originally located in an organ, even after...

HPV vaccine provides long-term protection against cervical cancer

Jim Cornall -
HPV vaccination reduces the risk of cervical cancer for at least 18 years, according to a new study from...

First in-utero stem cell therapy for foetal spina bifida repair is safe, study finds

Jim Cornall -
A phase 1 clinical trial published in The Lancet has shown that combining stem cell therapy with standard fetal...

First medicine for allergic fungal rhinosinusitis gets US approval

Jim Cornall -
Regeneron Pharmaceuticals, Inc. and Sanofi have announced that the U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab)...

Asahi Kasei to acquire Aicuris to accelerate growth in severe infectious diseases

Jim Cornall -
Aicuris Anti-infective Cures AG has entered into a definitive agreement under which Asahi Kasei, through its wholly owned US...

Promising results for rare paediatric epilepsy treatment

Jim Cornall -
Cerecin Inc. has announced the publication of a phase 1/2a clinical study evaluating the investigational drug CER-0001 (tricaprilin) for...

Next-generation flu vaccine development financed by EU

Jim Cornall -
SK bioscience, IDT Biologika (IDT) and Vaxxas have been selected for phase 1 of a next-generation vaccine development initiative...

Panome Bio looks to new metabolomics data solution for biomarker discovery and drug development

Jim Cornall -
Panome Bio, a multi-omics contract research organisation, has launched MassID, a cloud-based computational platform designed to improve how researchers...

Valinor and Renew partner to generate largest neurological disease multi-omics dataset

Jim Cornall -
Valinor Discovery and Renew Biotechnologies are set to collaborate to generate the largest clinical multi-omics dataset to date for...

New lab to speed up diagnostic innovation for biotech and pharma partners

Jim Cornall -
ARUP Laboratories, the largest nonprofit reference laboratory in the US, has launched an Innovation Central Laboratory to facilitate collaboration...

Gallbladder cancer could soon be detected in blood

Jim Cornall -
Researchers at Tezpur University in Assam, India, working with scientists at the University of Illinois Urbana-Champaign, have identified distinct...

Base to Base biotech podcast 48: GPCRs and beating neurodegenerative diseases

Jim Cornall -
The conversations on this week’s podcast are with CEO of Merz Therapeutics, Stefan König, about a variety of neurodegenerative...

Pfizer metastatic colorectal cancer treatment gets FDA approval

Jim Cornall -
Pfizer Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted full approval to BRAFTOVI (encorafenib)...

Every Cure to receive up to $76m to advance AI-identified drug repurposing opportunities

Jim Cornall -
Every Cure, a nonprofit with a mission to save and improve lives by repurposing existing medicines, has been selected...

Deeptech Digest is your guide to what's new in at the cutting edge of science technology. A bit of artificial intelligence, some biotech, and all the news and latests developments in the field. If it's deeptech, it's in Deeptech Digest!

Contact us: jim@deeptechdigest.com

© 2023 Ayr Coastal Media